Related Experiment Videos
Development of a compact extracorporeal membrane oxygenation (ECMO) system
A Funakubo1, I Sakuma, Y Fukui
1Faculty of Science and Engineering, Tokyo Denki University, Saitama, Japan.
Artificial Organs
|February 1, 1991
Summary
A new compact extracorporeal membrane oxygenation (ECMO) system effectively supports neonates with respiratory failure. This innovative device demonstrates efficient gas exchange and minimal complications in animal studies, showing promise for clinical application.
Area of Science:
- Biomedical Engineering
- Neonatal Intensive Care
- Respiratory Physiology
Background:
- Neonatal respiratory failure is a critical condition requiring advanced support.
- Extracorporeal membrane oxygenation (ECMO) is a life-saving therapy for severe respiratory distress in neonates.
- Existing ECMO systems can be cumbersome and require significant blood volume, posing challenges for neonates.
Purpose of the Study:
- To develop and evaluate a prototype of a compact extracorporeal membrane oxygenation (ECMO) system specifically designed for neonates.
- To assess the system's efficacy in providing respiratory support and its impact on physiological parameters.
- To determine the safety and applicability of the novel ECMO system for neonatal respiratory aid.
Main Methods:
- Development of a compact ECMO system featuring a single-lumen catheter for blood withdrawal/infusion and a hollow-fiber membrane lung.
- Implementation of a microcomputer-controlled system to manage withdrawal/infusion ratios, preventing plasma free hemoglobin increase.
- Evaluation of the system's performance in animal experiments, measuring oxygen (O2) and carbon dioxide (CO2) transfer rates and plasma free hemoglobin levels.
Main Results:
- The compact ECMO system demonstrated efficient O2 and CO2 exchange, capable of compensating for respiratory failure induced by mechanical ventilation.
- The system operated with a low priming volume (<90 ml), enabling ECMO without additional blood transfusions.
- After 6 hours of use, the increase in plasma free hemoglobin was minimal (4 mg/dl), indicating a safe interaction with blood.
Conclusions:
- The developed compact ECMO system is a promising technological advancement for neonatal respiratory support.
- Its efficient gas exchange, low priming volume, and minimal hemolysis suggest significant potential for clinical use in neonates.
- Further application as a respiratory support system in neonates is warranted based on the successful animal study outcomes.